Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11414451 Floxuridine synthesis

Patent 11414451 was granted and assigned to NuCana on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
NuCana
NuCana
0
Date Filed
September 18, 2018
0
Date of Patent
August 16, 2022
0
Patent Applicant
NuCana
NuCana
0
Patent Application Number
16647592
0
Patent Citations
‌
US Patent 10022390 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
‌
US Patent 10786523 Formulation comprising a gemcitabine-prodrug
‌
US Patent 11040051 Formulation comprising a gemcitabine-prodrug
‌
US Patent 10117888 Formulation comprising a gemcitabine-prodrug
0
Patent Citations Received
‌
US Patent 11786544 Formulations of phosphoramidate derivatives of nucleoside drugs
Patent Inventor Names
Mani Bushan Kotala
0
Venkata Lakshmi Narasimha Rao Dammalapati
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11414451
0
Patent Primary Examiner
‌
Traviss C Mcintosh, III
0

Find more entities like US Patent 11414451 Floxuridine synthesis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo